Pneumonyssoides caninum infection – a risk factor for gastric dilatation-volvulus in dogs

The pathophysiology, clinical course and therapeutic management of gastric dilatation-volvulus (GDV) in dogs are well known. However, the aetiology remains elusive. Aerophagia has often been put forward as a contributing cause of GDV. The most common clinical sign in dogs with nasal mite (Pneumonyssoides caninum) infection is reversed sneezing, which may result in aerophagia. A prospective one-year necropsy study was conducted. Of 250 dogs, 17 were GDV cases and, of these, 35% had concurrent nasal mite infection compared to 5% in the control population. Multivariate logistic regression analyses performed using the 187 dogs with complete records included nasal mite infection status, age, weight and gender. Nasal mite infection was found to be the most important risk factor for GDV in this study, with an odds ratio and confidence interval of 27.6 (4.8–157.5). Other risk factors that were marginally significant included weight and age with odds ratios of 1.08 (1.02–1.13) and 1.37 (1.04–1.79), respectively. Gender was not found to be a significant risk factor for GDV. This study suggests that nasal mite infection may contribute to the development of GDV in otherwise predisposed dogs.     

Interaction between probiotic lactic acid bacteria and canine enteric pathogens: a risk factor for intestinal Enterococcus faecium colonization?

Selected probiotic lactic acid bacteria (LAB) have been shown to elicit positive health effects particularly in humans. Competitive exclusion of pathogens is one of the most important beneficial health claims of probiotic bacteria. The effect of probiotic LAB on competitive exclusion of pathogens has been demonstrated in humans, chicken and pigs. In this study we evaluated the ability of certain LAB strains (Lactobacillus rhamnosus GG, Bifidobacterium lactis Bb12, Lactobacillus pentosus UK1A, L. pentosus SK2A, Enterococcus faecium M74 and E. faecium SF273) to inhibit the adhesion of selected canine and zoonotic pathogens (Staphylococcus intermedius, Salmonella Typhimurium ATCC 14028, Clostridium perfringens and Campylobacter jejuni) to immobilised mucus isolated from canine jejunal chyme in vitro. Adhesion of C. perfringens was reduced significantly by all tested LAB strains, between 53.7 and 79.1% of the control without LAB, the LAB of canine origin yielding the best reduction. The adhesion of S. Typhimurium and S. intermedius were not significantly altered by any of the LAB included in the study. Both enterococci tested significantly enhanced the adhesion of C. jejuni, to 134.6 and 205.5% of the control without LAB. E. faecium may thus favor the adhesion and colonization of C. jejuni in the dog's intestine, making it a potential carrier and possibly a source for human infection. Enhanced C. jejuni adhesion is a new potential risk factor of enterococci. Our results further emphasize the importance of safety guidelines to be established for the probiotics intended for animal use.     

The future of veterinary parasitology: a time for change?

The future of veterinary parasitology is discussed at a time when R&D funding from the pharmaceutical industry is declining, yet the opportunities for veterinary parasitologists to diversify their activities has never been greater. Emerging and re-emerging areas requiring input from veterinary parasitologists include: veterinary public health; conservation and wildlife diseases; emerging and exotic infectious diseases; surveillance strategies; economic effects of parasitic diseases; aquaculture; molecular epidemiology; dietary and biological control of parasitic diseases; animal welfare; organic agricultural systems; novel vaccination strategies; drug target characterisation and rational drug design. Without change, the survival of veterinary parasitology as a viable, distinct discipline is under threat. In this environment, veterinary parasitologists must be adaptable, imaginative and pro-active in terms of setting the agendas for establishing strategic alliances, promoting research needs and developing research programs.     

Will breed-specific legislation reduce dog bites?

So how do we deal with biting dogs? To start with, we must remind ourselves that biting is a natural activity of all dogs, and that there is potential for injury. All dog owners must understand this and must be made aware that they are fully responsible for the actions of their dogs. I am not convinced that this is universally understood by dog owners, nor am I satisfied that every dog owner takes the necessary steps to train and socialize their dog. Owners need to be encouraged to actively work at inhibiting biting behaviour when dogs are young. As well, all dogs should be socialized to accept children, regardless of whether or not there are children living with the dog. Adults without dogs need to learn that dogs don''t understand "people''s rights," and that dogs should not be expected to act differently with different people. Adults also need to understand that young children should never be left alone with a dog (or a cat) without supervision, and that all children should be taught how to behave around dogs, particulary around dogs they don''t know. So long as we have dogs living with us there will be people who get bitten. The most effective way to prevent bites is to encourage dog owners to become knowledgeable about their animals and to train and socialize them so that they can become good dog neighbours. Many municipalities already have by-laws that deal with animal bites, and in Ontario the Dog Owners Liability Act has proven to be effective in confining, restraining or disposing of biting or attacking dogs judged to be a definite threat to public health and safety, and when evidence warrants, there is always Section #221 of the Criminal Code of Canada. Most legislation deals with bites after the fact. If we want to prevent all bites, there is only one sure way and that is to ban all dogs. That is of course as unrealistic as trying to prevent bites by enacting breed specific legislation.     

Modern biotechnology: a new box for Pandora?

In a bird's-eye view attention has been paid to a number of items of biotechnology. Amongst others to the beginning of the recombinant DNA technology or genetic modification. Mentioned are the bull Herman, the American tomato 'Flavr Savr' and the sheep Dolly. And further something about the supporters and the opponents of genetic modification and the safety of it. The why of transgenic plants and animals. The legislation and the Netherlands as possible transgene-production country.     

The aging feline kidney: a model mortality antagonist?

Traditional thinking views apparently non-programmed disruptions of aging, which medical science calls geriatric diseases, as separate from 'less harmful' morphological and physiological aging phenotypes that are more universally expected with passage of time (loss of skin elasticity, graying of hair coat, weight gain, increased sleep time, behavioral changes, etc). Late-life disease phenotypes, especially those involving chronic processes, frequently are complex and very energy-expensive. A non-programmed process of homeostatic disruption leading into a death trajectory seems inconsistent with energy intensive processes. That is, evolutionary mechanisms do not favor complex and prolonged energy investment in death. Taking a different view, the naturally occurring feline (Felis silvestris catus) renal model suggests that at least some diseases of late life represent only the point of failure in essentially survival-driven adaptive processes. In the feline renal model, individuals that succumbed to failure most frequently displayed progressive tubular deletion and peritubular interstitial fibrosis, but had longer mean life span than cats that died from other causes. Additionally, among cats that died from non-renal causes, those that had degrees of renal tubular deletion and peritubular interstitial fibrosis also had longer mean life span than those cats with no changes, even though causes of death differed minimally between these latter two groups. The data indicate that selective tubular deletion very frequently begins early in adult life, without a clear initiating phase or event. The observations support a hypothesis that this prolonged process may be intrinsic and protective prior to an ultimate point of failure. Moreover, given the genetic complexity and the interplay with associated risk factors, existing data also do not support the ideas that these changes are simple compensatory responses and that breed- or strain-based 'default' diseases are inevitable results of increasing individual longevity. Emerging molecular technology offers the future potential to further evaluate and refine these observations. At present, the existence of plastic and adaptive aging programming is suggested by these findings.     

S-methylcysteine sulphoxide,the brassica anaemia factor (a valuable dietary factor for man?)

Ruminant animals fed mainly or exclusively on brassica crops may develop a severe Heinz body anaemia. Clinical signs of the disease include haemoglobinuria, jaundice, increase in pulse rate and fall in milk production; there may also be growth retardation. Nitrate and thiocyanates were excluded as primary haemolytic factors in kale which contains up to 2% in DM of S-methylcysteine sulphoxide (SMCO). In test goats, daily intakes of SMCO in the range 15 to 19 g/100 kg liveweight, whether given as kale or the pure synthetic compound, elicited comparable haemolytic responses. SMCO was thus implicated as the major primary toxin in brassica poisoning. Rumen organisms converted SMCO into dimethyl disulphide which mimicked the haemolytic action of kale and SMCO in goats and is thus considered to be the secondary haemolysin. The practical consequence of this disulphide mechanism is that, because there is no simple way of counteracting the systemic action of dimethyl disulphide, prophylactic measures are restricted to limiting the intake of SMCO or to inhibiting disulphide production. Manipulation of rumen flora by dietary means to exclude organisms with SMCO-lyase is seen as a possible way of minimising the problem which in the long term however calls for developing brassica varieties with low SMCO content. The SMCO content of leafy brassicas increases as the plants mature; within a single plant highest SMCO levels are found in young leaves and growing shoots. SMCO is a heritable character and its selection will probably not lead to marked changes in protein or carbohydrate contents. In steers acute haemolytic response with growth inhibition was obtained with daily SMCO intakes, given as cabbage, of 18 to 35 g/100 kg liveweight. At the lower daily intake of 10–15 g the response was sub-acute, but the low grade anaemia produced would probably be incompatible with maximum productivity. Daily intakes below 10 g/100 kg generally lead to mild disturbances only in blood picture; and it is speculated that, on balance, at this level the effects of SMCO may even be beneficial to the animal. The possible prophylactic action of the S-alkylcysteine sulphoxides in coronary heart disease in man is briefly discussed.Resume Les ruminants nourris principalement ou exclusivement de crucifères peuvent contracter une grave anémie à corpuscules endoglobulaires. Les signes cliniques de la maladie comprennent l'hémoglobinurie, la jaunisse, l'élévation du pouls et la baisse de la production de lait et éventuellement aussi un retard de la croissance. Le nitrate et les thiocyanates ont été exclus comme facteurs hémolytiques primaires du chou à feuilles, qui contient jus qu'à 2% en matières sèches du sulfoxyde de s-méthylcystéine (SMCO). Chez les chèvres utilisées comme sujets d'expériences, des doses quotidiennes de SMCO de l'ordre de 15 à 19 g par 100 kg de poids corporel, absorbée sous la forme de chou ou sous celle de composé synthétique pur ont donné des réactions hémolytiques comparables. On a donc conclu que le SMCO était la principale toxine primaire responsable de l'empoisonnement brassicaire. Les organismes du rumen ont transformé le SMCO en disulphide de diméthyle qui a reproduit l'action hémolytique du chou et du SMCO chez les chèvres, et qui est donc considéré comme l'hémolysine secondaire. Étant donné qu'il n'y a pas de moyens simples de contrecarrer l'action systémique du disulphide de diméthyle, les seules mesures prophylactiques sont la limitation de l'absorption de SMCO ou l'inhibition de la production de disulphide. L'action sur la flore du rumen par des moyens diététiques, à fin d'exclure les organismes à SMCO-lyase, semble un moyen possible d'atténuer le problème. Mais à long terme, il faudra développer des variétés de crucifères à faible teneur en SMCO. La teneur en SMCO des crucifères feuillus augmente au fur et à mesure de la maturation. Sur une même plante, les teneurs les plus élevées se rencontrent dans les jeunes feuilles et dans les pousses en croissance. Le SMCO est un caractère héréditaire et une sélection operée en fonction de lui n'entraînera probablement pas de modifications importantes des teneurs en protéines ou en hydrates de carbone. Une réaction hémolytique aiguë avec inhibition de la croissance a été provoquée chez les bouvillons au moyen de doses quotidiennes de SMCO de 18 à 35 g par 100 kg de poids corporel, administrées sous forme de chou. A la dose quotidienne plus faible de 10 à 15 g la réaction a été sub-aiguë mais l'anémie faible qui en résulte serait probablement incompatible avec une productivité optimale. Les doses quotidiennes inférieures à 10 g par 100 kg ne provoquent généralement que de légères perturbations de la formule hématologique. On estime qu'à ce taux les effets du SMCO peuvent même, dans l'ensemble, être bénéfiques à l'animal. L'action prophylactique possible des sulfoxydes de s-alkylcysteine dans les cas de maladies coronaires chez l'homme est examinée brièvement.

---

Kurzfassung Bei Wiederkäuern, die hauptsächlich oder ausschliesslich Brassica-Futter erhalten, kann es zu einer schweren Innenkörperanämie kommen. Klinische Anzeichen hierfür sind u.a. Bluthernen, Gelbsucht, erhöhte Pulsfrequenz und Rückgang der Milcherzeugung, ausserdem unter Umständen ein verlangsamtes Wachstum. Nitrat und Thiocyanat wurden als primäre hämolytische Faktoren im Brassica oleracea, das bis zu 2% S-Methylcystein sulfoxid (SMCO) in der Trockenmasse enthält, ausgeschlossen. Bei Test-Ziegen führten Tagesdosen von SMCO im Bereich von 15 bis 19 g/100 kg Lebendgewicht in Form von Brassica oleracea oder dem reinen, synthetisierten Bestandteil zu vergleichbaren hämolytischen Reaktionen. SMCO war also als wichtigstes Primärtoxin bei Brassica-Vergiftungen beteiligt. Die Pansenorganismen setzten SMCO in Dimethyldisulfid um, das die selbe hämolytische Wirkung wie Brassica oleracea und SMCO bei Ziegen hatte und so als sekundäres Hämolysin gilt. Die praktische Folge dieses Disulfidmechanismus ist, dass vorbeugende Massnahmen auf die Begrenzung der SMCO-Aufnahme oder die Verhinderung der Disulfidproduktion beschränkt sind, da es keine einfache Möglichkeit gibt, der systematischen Aktion von Dimethyldisulfid entgegenzuwirken. Eine Manipulation der Pansenflora durch entsprechende Ernährung zur Ausschaltung von Organismen mit SMCO-Lyase gilt als Möglichkeit zur Minimalisierung des Problems, das langfristig gesehen jedoch die Entwicklung von Brassica-Arten mit geringem SMCO-Gehalt erforderlich macht. Der SMCO-Gehalt von Blattkohl nimmt mit zunehmender Reife der Pflanze zu; innerhalb einer Pflanze findet sich der grösste SMCO-Gehalt in jungen Blättern und wachsenden Trieben. SMCO ist ein erbliches Merkmal, und seine Selektion wird vermutlich nicht zu grösseren Aenderungen im Protein-oder Kohlehydratgehalt führen. Bei Ochsen wurde eine akute hämolytische Reaktion mit Wachstumsverzögerung bei täglichem SMCO-Dosen von 18 bis 35 g/100 kg Lebendgewicht in Form von Kohl erzielt. Bei der geringeren Tagesdosis von 10–15 g war die Reaktion subakut, die entwickelte geringfügige Anämie wäre jedoch vermutlich mit maximaler Produktivität unvereinbar. Tagesdosen unter 10 g/100 kg führen im allgemeinen nur im Blutbild zu geringen Störungen; man vermutet, dass alles in allem SMCO bei dieser Dosierung sogar eine positive Auswirkung auf das Tier haben kann. Die mögliche prophylaktische Wirkung der S-Alkylcystein sulfoxide bei Erkrankungen der Herzkranzgefässe beim Menschen wird kurz erörtert.

---

Riassunto I ruminanti la cui dieta è in gran parte o esclusivamente rappresentata da cavoli (Brassica spp.) possono essere colpiti da una grave forma di anemia (Heinz body anaemia). I sintomi clinici della malattia comprendono emoglobinuria, ittero, aumento della frequenza cardiaca e caduta della produzione lattea. A volte si può anche avere ritardo della crescita. I nitrati e i tiocianati sono stati esclusi come fattori emolitici primari nei cavoli che contengono fino al 2% in DM di S-metilcisteina sulfossido (SMCO). In experimenti condotti sulle capre, la somministrazione giornaliera di SMCO in dosi di 15–19 g/100 kg di peso vivo, sia sotto forma di vegetale che di prodotto sintetico puro, ha provocato fenomeni emolitici relativamente simili. L'SMCO è stato pertanto indicato come la principale tossina che ha un ruolo primario nell'intossicazione da cavoli. La flora ruminale converte infatti l'SMCO in dimetil bisolfuro, il quale svolge un'azione emolitica simile a quella osservata nelle capre dopo l'assunzione di cavoli e di SMCO; il dimetil bisolfuro, pertanto, e ritenuto costituire l'emolisina secondaria. Le conseguenze pratiche di tale produzione di dimetil bisolfuro è che, non esistendo un metodo semplice per contrastare l'azione sistemica del dimetil bisolfuro, le misure profilattiche non possono essere volte ad altro se non a limitare l'assunzione di SMCO o ad inibire la produzione di bisolfuro. Gli interventi sulla flora del rumine mediante una dieta capace di eliminare i microrganismi provvisti di SMCO-liasi vengono considerati come un possibile mezzo per minimizzare il problema, il quale, tuttavia, se visto a lungo termine, richiede la creazione di varietà di cavoli a basso contenuto di SMCO. Il contenuto di SMCO delle foglie dei cavoli aumenta col maturare della pianta: nella pianta singola i livelli piu alti di SMCO si riscontrano nelle foglie giovani e nei germogli. La presenza di questa sostanza costituisce un carattere ereditario ed un intervento selettivo in tal senso non dovrebbe condurre a significative alterazioni del contenuto in proteine e carboidrati della pianta. Nei vitelloni e stato possibile indurre una risposta emolitica di tipo acuto somministrando giornalmente, sotto forma di cavoli, 18–35 g di SMCO per 100 kg di peso vivo. Un' assunzione giornaliera minore, pari a 10–15 g, ha dato luogo ad una forma emolitica subacuta, ma e tuttavia da ritenere che la lieve anemia cosi indotta non sia compatibile con una produttività ottimale. Livelli giornalieri al di sotto dei 10 g/100 kg hanno causato soltanto lievi alterazioni a carico del quadro ematico, ed è stata avanzata l'ipotesi che, tutto sommato, gli effetti dell'SMCO possano, a questi livelli, essere addirittura di beneficio all'animale. Viene discussa brevemente la possibile azione preventiva degli S-alchilcisteina sulfossidi sulle malattie cardio-coronariche dell'uomo.

     

Heck cattle in the Oostvaardersplassen: risk for infectious diseases or not?

This article discusses risk analysis of infectious diseases in a cattle population. Heck cattle living in nature reserve 'De Oostvaardersplassen' were studied as an example of the risk analysis approach. Twenty-five adult cattle were tested for every infectious disease agent that the risk analysis indicated might be prevalent. All sampled cattle tested positive for Bovine Herpesvirus 1, whereas the prevalence of antibodies against other infectious disease agents was below the level that was assumed to be the threshold for spread of the disease to cattle in the surrounding areas. Risk management of infectious diseases was expressed in a so-called 'low-risk profile'. The risk of introduction or spread of infectious diseases was estimated to be very low as long as the population was kept strictly enclosed.